Oncology
-
Steve Saviuk of Valeo Pharma talks about revenue growth following impressive market gains
In this InvestorIntel interview with host Tracy Weslosky, Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO…
-
Valeo Pharma is cashed up and ready to expand as COVID restrictions end
Are we starting to see the beginning of the end of COVID’s reign of terror over humanity? I…
-
Dr. Charles Meakin on the benefits of StageZero Life Sciences early diagnostic cancer test
In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Charles Meakin, Chief Medical Officer at CareOncology.com on…
-
Revenue Forecasted to Triple as Valeo Benefits from Last Year’s Successes
Valeo Pharma Inc. (CSE: VPH | OTC: VPHIF |FSE: VP2) is a specialty pharmaceutical company and its revenue…
-
Kozak on how Valeo Pharma’s innovative natural health-based product lines are carving their niche in specialty pharmaceuticals
“Valeo is focused on those therapeutic fields where a relatively small number of general practitioners or specialist physicians…
